Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review

被引：42
|
作者：
Uppendahl, Locke D. [1 ]
Dahl, Carly M. [2 ]
Miller, Jeffrey S. [3 ]
Felices, Martin [3 ]
Geller, Melissa A. [1 ]
机构：
[1] Univ Minnesota, Sch Med, Div Gynecol Oncol, Dept Obstet Gynecol & Womens Hlth, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Sch Med, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA
来源：
FRONTIERS IN IMMUNOLOGY | 2018年 / 8卷
关键词：
natural killer cells; immunotherapy; gynecologic malignancy; ovarian cancer; cervical cancer; TUMOR-INFILTRATING LYMPHOCYTES; APOPTOSIS-INDUCING LIGAND; OVARIAN-CANCER PATIENTS; CLASS-I MOLECULES; ANTI-CD20; MONOCLONAL-ANTIBODY; PERIPHERAL-BLOOD LYMPHOCYTES; IFN-GAMMA PRODUCTION; UTERINE NK CELLS; ACTIVATING RECEPTOR; ADOPTIVE TRANSFER;
D O I：
10.3389/fimmu.2017.01825
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Harnessing the immune system has proven an effective therapy in treating malignancies. Since the discovery of natural killer (NK) cells, strategies aimed to manipulate and augment their effector function against cancer have been the subject of intense research. Recent progress in the immunobiology of NK cells has led to the development of promising therapeutic approaches. In this review, we will focus on the recent advances in NK cell immunobiology and the clinical application of NK cell immunotherapy in ovarian, cervical, and uterine cancer.
引用
收藏
页数：15
相关论文
共 50 条
  • [31] Nanomaterials for Natural Killer Cell-Based Immunoimaging and Immunotherapies in Cancer
    Uthaman, Saji
    Cutshaw, Gabriel
    Ghazvini, Saman
    Bardhan, Rizia
    ACS APPLIED MATERIALS & INTERFACES, 2022, 15 (44) : 50708 - 50720
  • [32] A Transformable Supramolecular Bispecific Cell Engager for Augmenting Natural Killer and T Cell-Based Cancer Immunotherapy
    Chen, Yumiao
    Li, Wei
    Wang, Zhongqiu
    Yu, Yingying
    Li, Jie
    Ding, Yinghao
    Hu, Zhiwen
    Liu, Qian
    Yang, Zhimou
    Gao, Jie
    ADVANCED MATERIALS, 2024, 36 (03)
  • [33] Natural Killer Cell Immunotherapy for Osteosarcoma
    Tullius, Brian P.
    Setty, Buhvana A.
    Lee, Dean A.
    CURRENT ADVANCES IN OSTEOSARCOMA: CLINICAL PERSPECTIVES: PAST, PRESENT AND FUTURE, 2ND EDITION, 2020, 1257 : 141 - 154
  • [34] The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
    Rezvani, Katayoun
    Rouce, Rayne H.
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [35] NK cell-based immunotherapy for cancer
    Fang, Fang
    Xiao, Weihua
    Tian, Zhigang
    SEMINARS IN IMMUNOLOGY, 2017, 31 : 37 - 54
  • [36] Natural killer cell immunotherapy: from bench to bedside
    Domogala, Anna
    Madrigal, J. Alejandro
    Saudemont', Aurore
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [37] Natural killer cell-based immunotherapy: From transplantation toward targeting cancer stem cells
    Dianat-Moghadam, Hassan
    Rokni, Mohsen
    Marofi, Faroogh
    Panahi, Yunes
    Yousefi, Mehdi
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (01) : 259 - 273
  • [38] miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy
    Pesce, Silvia
    Greppi, Marco
    Ferretti, Elisa
    Obino, Valentina
    Carlomagno, Simona
    Rutigliani, Mariangela
    Thoren, Fredrik B.
    Sivori, Simona
    Castagnola, Patrizio
    Candiani, Simona
    Marcenaro, Emanuela
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [39] Natural killer cell activation and dendritic cell-based vaccines
    Osada, T.
    Clay, T. M.
    Woo, C. Y.
    Morse, M. A.
    Lyerly, H. Kim
    MINERVA BIOTECNOLOGICA, 2007, 19 (03) : 91 - 104
  • [40] DNT Cell-based Immunotherapy: Progress and Applications
    Li, Yingrui
    Dong, Kang
    Fan, Xueke
    Xie, Jun
    Wang, Miao
    Fu, Songtao
    Li, Qin
    JOURNAL OF CANCER, 2020, 11 (13): : 3717 - 3724
12345